Drugs / Polysporin
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | POLYSPORIN | — | 1974-04-16 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00695578 | Oct 2006 → Jun 2007 | actinic keratosis | Wake Forest University | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1/2 | NCT05000983 Comparator | Oct 2021 → Nov 2028 expected | — | University of Manitoba | Recruiting | No outcome recorded |
| Phase 1/2 | NCT04893863 Comparator | Oct 2021 → Dec 2028 expected | — | University of Manitoba | Recruiting | No outcome recorded |
| Phase 2/3 | NCT00674999 Comparator | Jun 2005 → Sep 2008 | — | The University of Texas Medical Branch, Galveston | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polysporin | “Topical antibiotic ointment (Polysporin™ or formulary equivalent) and non-adherent petrolatum fine-meshed gauze (ADAPTIC™) applied every Monday, Wednesday and Friday (or equivalent).” NCT04893863 ↗3“Topical antibiotic ointment (Polysporin™ or formulary equivalent)” NCT05000983 ↗ |
| Route | Topical | “over the counter Polysporin ointment 3 times daily for 4 weeks to wounds” NCT00695578 ↗ |